Hydrochloric Acid → 5,5-dimethyl-3-[3-[(4-oxo-5,6,7,8-tetrahydro-3H-phthalazin-1-yl)methyl]phenyl]imidazolidine-2,4-dione
反応式
[CH3:1][C:2]([NH:8][C:9](=[O:29])[NH:10][C:11]1[CH:16]=[CH:15][CH:14]=[C:13]([CH2:17][C:18]2[C:27]3[CH2:26][CH2:25][CH2:24][CH2:23][C:22]=3[C:21](=[O:28])[NH:20][N:19]=2)[CH:12]=1)([CH3:7])[C:3]([O:5]C)=O.[OH-].[Na+].Cl>CN(C=O)C>[CH3:7][C:2]1([CH3:1])[NH:8][C:9](=[O:29])[N:10]([C:11]2[CH:16]=[CH:15][CH:14]=[C:13]([CH2:17][C:18]3[C:27]4[CH2:26][CH2:25][CH2:24][CH2:23][C:22]=4[C:21](=[O:28])[NH:20][N:19]=3)[CH:12]=2)[C:3]1=[O:5]参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of methyl 2-methyl-2-[[3-[(4-oxo-5,6,7,8-tetrahydro-3H-phthalazin-1-yl)methyl]phenyl]carbamoylamino]propanoate (14) (44 mg, 0.11 mmol) in dry DMF (2 mL) was added finely powdered sodium hydroxide (4 mg, 0.072 mmol). The reaction mixture was immersed in a preheated oil bath at 50° C. for 5 hours, before being neutralized by addition of 1M HCl The desired product was isolated from the resultant solution by preparative chromatography to yield a solid (3.6 mg, 98% purity). M/z (LC-MS, ESP), RT=7.69 mins (M+H 367.1).
出典と根拠
- ORDレコード
- ord-c485a3fa48f245b0abdaf29b7fbf93f5
- 出典データセット
- uspto-grants-2011_07
- 特許番号
- US07981890B2
反応ノート
読み込み中…